Retinoic acid metabolism blocking agents (RAMBAs): a new paradigm in the treatment of hyperkeratotic disorders
- 17 December 2007
- journal article
- review article
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 6 (5) , 355-364
Abstract
Summary: Synthetic vitamin A derivatives, retinoids,have long been the mainstay of treatment for several disorders of keratinization, notably the ichthyoses and severe acne. Some forms of psoriasis also respond well. Their considerable power comes at a price.They have dose‐limiting side effects and can be highly teratogenic, limiting their use in women of childbearing age.Thus, retinoids are used less often than their potential would warrant. However, the recent development of compounds that block the catabolism of endogenous vitamin A, called Retinioic Acid Metabolism Blocking Agents or RAMBAs, offers new possibilities. With these drugs, retinoid effects with less side effects and a reduction of the post‐treatment teratogenicity period due to their favourable pharmacokinetic profile might be expected. In this review, we discuss how retinoids work, how they are metabolized and how RAMBAs influence this process.We also review the presently available data from clinical trials with RAMBAs.Keywords
This publication has 82 references indexed in Scilit:
- Cellular Transport and Metabolism of Vitamin A: Roles of the Cellular Retinoid-Binding ProteinsNutrition Reviews, 2009
- Psoriasis is associated with lipid abnormalities at the onset of skin diseaseJournal of the American Academy of Dermatology, 2006
- Retinoic acid metabolismJournal of the American Academy of Dermatology, 2001
- Identification and Tissue Distribution of the Novel Human Cytochrome P450 2S1 (CYP2S1)Biochemical and Biophysical Research Communications, 2001
- Nuclear Receptor Coregulators: Cellular and Molecular BiologyEndocrine Reviews, 1999
- LiarozoleDrugs & Aging, 1996
- Structure/Function of Cytoplasmic Vitamin A-Binding ProteinsAnnual Review of Nutrition, 1996
- Structure and Regulation of the Gene Encoding the Neuron-specific Protein Kinase C Substrate Neurogranin (RC3 Protein)Journal of Biological Chemistry, 1995
- Experimental studies with liarozole (R 75 251): An antitumoral agent which inhibits retinoic acid breakdownThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRαNature, 1992